Phenotypic diversity in hypertrophic cardiomyopathy

Human Molecular Genetics

Volumn 11, Issue 20, 2002, Pages 2499-2506

  Arad, Michael ^a   Seidman, J G ^a   Seidman, Christine E ^a,b,c  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLOSPORIN A; DILTIAZEM; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONTROLLED STUDY; DISEASE COURSE; GENE MUTATION; GENETIC HETEROGENEITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN GENETICS; HYPERTROPHIC CARDIOMYOPATHY; MOLECULAR GENETICS; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; PATHOGENESIS; PHENOTYPIC VARIATION; POPULATION GENETICS; PRIORITY JOURNAL; REVIEW;

ANIMALIA;

EID: 0036796263     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/11.20.2499     Document Type: Review

References (60)

1. Seidman, C.E. and Seidman, J.G. (2001) Hypertrophic cardiomyopathy. In Scriver, C.R., Beaudet, A.L., Sly, W.S., Valle, D., Childs, B., Kinzler, K.W. and Vogelstein, B. (eds), The Metabolic and Molecular Basis of Inherited Disease, 8th edn. McGraw-Hill, New York, Vol. IV, pp. 5433-5438.
2. Roberts, R. and Sigwart, U. (2001) New concepts in hypertrophic cardiomyopathy. Circulation, 104, 2113-2116, 2249-2252.
3. Marian, A.F. and Roberts, R. (2001) The molecular basis for hypertrophic cardiomyopathy. J. Molec. Cell. Cardiol., 33, 655-670.
4. Regitz-Zagrosek, V, Erdmann, J., Tanis, N, Senyuva, M., Werner, U., Raible, J., Kotsch, K., Elsner, A., Hummel, M. and Hetzer, R. (2001) Mutation spectrum in six disease genes in a large cohort of index patients with hypertrophic cardiomyopathy. Circulation, 104, II-21 (abst.).
5. Richard, R, Charron, R, Carrier, L., Ledeuil, C., Dubourg, O., Desnos, M., Bouhour, J.B., Schwartz, K., Haique, B. and Komajda, M. (2001). Distribution of disease genes in 102 genotyped families with hypertrophic cardiomyopathy. Circulation, 104, II-531 (abst.).
6. Underhill, P.A., Jin, L., Lin, A.A., Mehdi, Q., Jenkins, T., Vollrath, D., Davis, R.W., Cavalli-Sforza, L.L. and Oefner, P.J. (1997) Detection of numerous Y chromosome biallelic polymorphisms by denaturing high-performance liquid chromatography. Genome Res., 7, 996-1005.
7. Orita, M, Iwahana, H., Kanazawa, H., Hayashi, K. and Sekiya, T. (1989) Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc. Natl Acad. Sci. USA, 86, 2766-2770.
8. Greve, G., Bachinski, L., Friedman, D.L., Czernuzewicz, G., Anan, R., Towbin, J., Seidman, C.E. and Roberts, R. (1994) Isolation of a de novo mutant myocardial β MHC protein in a pedigree with hypertrophic cardiomyopathy. Hum. Mol. Genet., 3, 2073-2075.
9. Satoh, M., Takahashi, M., Sakamoto, T., Hiroe, M., Mariano, F. and Kimura, A. (1999) Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene. Biochem. Biophys. Res. Commun., 262, 411-417.
10. Davis, J.S., Hassanzadeh, S. Winitsky, S., Lin, H., Satorius, C., Vemuri, R., Aletras, A.H., Wen, H. and Epstein, N.D. (2001) The overall pattern of cardiac contraction depends on a spatial gradient of myosin regulatory light chain phosphorylation. Cell, 107, 631-641.
11. Geier, C., Oezcelik, C., Perrot, A., Bit-Avragim, N., Scheffold, T. and Osterziel, K.J. (2001) Muscle LIM protein: a novel disease gene for hypertrophic cardiomyopathy? Circulation, 104, 11-21 (abst.).
12. Marin-Garcia, J., Ananthakrishnan, R., Goldenthal, M.J., Filiano, J.J. and Perez-Atayde, A. (1997) Cardiac mitochondrial dysfunction and DNA depletion in children with hypertrophic cardiomyopathy. J. Inherit. Metab. Dis., 20, 674-680.
13. Sachdev, B., Takenaka, T., Teraguchi, H., Tei, C., Lee, R, McKenna, W.J. and Elliott, P.M. (2002) Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy. Circulation, 105, 1407-1411.
14. Gollob, M.H., Green, M.S., Tang, A.S., Gollob, T., Karibe, A., Hassan, A.S., Ahmad, E, Lozado, R., Shah, G., Fananapazir, L. et al. (2001) Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. N. Engl. J. Med., 344, 1823-1831.
15. 2 subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. Hum. Mol. Genet., 10, 1215-1220.
16. Arad, M., Benson, D.W, Perez-Atayde, A.R., McKenna, W.J., Sparks, E.A., Kanter, R.J., McGarry, K., Seidman, G.J. and Seidman, C.E. (2002) Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. J. Clin. Invest., 109, 357-362.
17. Klues, H.G., Schiffers, A. and Maron, B.J. (1995) Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J. Am. Coll. Cardiol., 26, 1699-1708.
18. Niimura, H., Bachinski, L.L., Sangwatanaroj, S., Watkins, H., Chudley, A.E., McKenna, W, Kristinsson, A., Roberts, R., Sole, M., Maron, B.J. et al. (1998) Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N. Engl. J. Med., 338, 1248-1257.
19. Erdmann, J., Raible, J., Maki-Abadi, J., Hummel, M., Hammann, J., Wollnik, B., Frantz, E., Fleck, E., Hetzer, R. and Regitz-Zagrosek, V. (2001) Spectrum of clinical phenotypes and gene variants in cardiac myosin-binding protein C mutation carriers with hypertrophic cardiomyopathy. J. Am. Coll. Cardiol., 38, 322-330.
20. Abchee, A. and Marian, A.J. (1997) Prognostic significance of beta-myosin heavy chain mutations is reflective of their hypertrophic expressivity in patients with hypertrophic cardiomyopathy. J. Invest. Med., 45, 191-196.
21. Moolman, J.C., Corfield, V.A., Posen, B., Ngumbela, K., Seidman, C., Brink, P.A. and Watkins, H. (1997) Sudden death due to troponin T mutations. J. Am. Coll. Cardiol., 29, 549-555.
22. Maron, B.J., Olivotto, I., Spirito, P., Casey, S.A., Bellone, P., Gohman, T.E., Graham, K.J., Burton, D.A. and Cecchi, F. (2000) Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. Circulation, 102, 858-864.
23. Spirito, R, Seidman, C.E., McKenna, W.J. and Maron, B.J. (1997) The management of hypertrophic cardiomyopathy. N. Engl. J. Med., 336, 775-785.
24. Niimura, H., Patton, K.K., McKenna, W.J., Soults, J., Maron, B.J., Seidman, J.G. and Seidman, C.E. (2002) Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly. Circulation, 105, 446-451.
25. Fananapazir, L. and Epstein, N.D. (1994) Genotype-phenotype correlations in hypertrophic cardiomyopathy. Insights provided by comparisons of kindreds with distinct and identical β-myosin heavy chain gene mutations. Circulation, 89, 22-32.
26. Kimura, A., Harada, H, Park, J.E., Nishi, H., Satoh, M., Takahashi, M., Hiroi, S., Sasaoka, T., Ohbuchi, N., Nakamura, T. et al. (1997) Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat Genet., 16, 379-382.
27. Kokado, H., Shimizu, M., Yoshio, H., Ino, H., Okeie, K., Emoto, Y., Matsuyama, T., Yamaguchi, M., Yasuda, T., Fujino, N. et al. (2000) Clinical features of hypertrophic cardiomyopathy caused by a Lys183 deletion mutation in the cardiac troponin I gene. Circulation, 102, 663-669.
28. Lechin, M., Quinones, M.A., Omran, A., Hill, R., Yu, Q.T., Rakowski, H., Wigle, D., Liew, C.C., Sole, M., Roberts, R. et al. (1995) Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. Circulation, 92, 1808-1812.
29. Brugada, R., Kelsey, W, Lechin, M., Zhao, G., Yu, Q.T., Zoghbi, W., Quinones, M., Elstein, E., Omran, A., Rakowski, H. et al. (1997) Role of candidate modifier genes on the phenotypic expression of hypertrophy in patients with hypertrophic cardiomyopathy. J. Invest. Med., 45, 542-551.
30. Tesson, F., Dufour, C., Moolman, J.C., Carrier, L., Al-Mahdawi, S., Chojnowska, L., Dubourg, O., Soubrier, E., Brink, P., Komajda, M. et al. (1997) The influence of the angiotensin I converting enzyme genotype in familial hypertrophic cardiomyopathy varies with the disease gene mutation. J. Mol. Cell. Cardiol., 29, 831-838.
31. Osterop, A.P., Kofflard, M.J., Sandkuijl, L.A., ten Cate, F.J., Krams, R., Schalekamp, M.A. and Danser, A.H. (1998) AT1 receptor A/C1166 polymorphism contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy. Hypertension, 32, 825-830.
32. Deinum, J., van Gool, J.M., Kofflard, M.J., ten Cate, F.J. and Danser, A.H. (2001) Angiotensin II type 2 receptors and cardiac hypertrophy in women with hypertrophic cardiomyopathy. Hypertension, 38, 278-281.
33. Patel, R., Lim, D.S., Reddy, D., Nagueh, S.F., Lutucuta, S., Sole, M.J., Zoghbi, W.A., Quinones, M.A., Roberts, R. and Marian, A.J. (2000) Variants of trophic factors and expression of cardiac hypertrophy in patients with hypertrophic cardiomyopathy. J. Mol. Cell. Cardiol., 32, 2369-2377.
34. Ortlepp, J.R., Vosberg, H.P., Reith, S., Ohme, F, Mahon, N.G., Schroder, D., Klues, H.G., Hanrath, P. and McKenna, W.J. (2002) Genetic polymorphisms in the renin-angiotensin-aldosterone system associated with expression of left ventricular hypertrophy in hypertrophic cardiomyopathy: a study of five polymorphic genes in a family with a disease causing mutation in the myosin binding protein C gene. Heart, 87, 270-275.
35. Marian, AJ, Yu, Q.T., Workman, R., Greve, G. and Roberts, R. (1993) Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet, 342, 1085-1086.
36. Ho, C.Y., Lever, H.M., DeSanctis, R., Farver, C.F., Seidman, J.G. and Seidman, C.E. (2002) Homozygous mutation in cardiac troponin T: implications for hypertrophic cardiomyopathy. Circulation, 102, 1950-1955.
37. Arbustini, E., Fasani, R., Morbini, P, Diegoli, M., Grasso, M., Dal Bello, B., Marangoni, E., Banfi, R, Banchieri, N., Bellini, O. et al. (1998) Coexistence of mitochondrial DNA and β myosin heavy chain mutations in hypertrophic cardiomyopathy with late congestive heart failure. Heart, 80, 548-558.
38. Arnett, D.K., Devereux, R.B., Kitzman, D., Oberman, A., Hopkins, P., Atwood, L., Dewan, A. and Rao, D.C. (2001) Linkage of left ventricular contractility to chromosome 11 in humans: the HyperGEN study. Hypertension, 38, 767-772.
39. Dimitrow, P.P., Czarnecka, D., Strojny, J.A., Kawecka-Jaszcz, K. and Dubiel, J.S. (2001) Impact of gender on the left ventricular cavity size and contractility in patients with hypertrophic cardiomyopathy. Int. J. Cardiol., 77, 43-48.
40. Lin, C.L., Chiang, C.W, Shaw, C.K., Chu, P.H., Chang, C.J. and Ko, Y.L. (1999) Gender differences in the presentation of adult obstructive hypertrophic cardiomyopathy with resting gradient: a study of 122 patients. Jpn Circ. J, 63, 859-864.
41. Van Camp, S.P., Bloor, C.M., Mueller, F.O., Cantu, R.C. and Olson, H.G. (1995) Nontraumatic sports death in high school and college athletes. Med. Sci. Sports Exerc., 27, 641-647.
42. Regitz-Zagrosek, V, Erdmann, J., Wellnhofer, E., Raible, J. and Fleck, E. (2000) Novel mutation in the alpha-tropomyosin gene and transition from hypertrophic to hypocontractile dilated cardiomyopathy. Circulation, 102, E112-E116.
43. Geisterfer-Lowrance, A.A., Christe, M., Conner, D.A., Ingwall, J.S., Schoen, F.J., Seidman, C.E. and Seidman, J.G. (1996) A mouse model of familial hypertrophic cardiomyopathy. Science, 272, 731-734.
44. Semsarian, C., Healey, M.J., Fatkin, D., Giewat, M., Duffy, C., Seidman, C.E. and Seidman, J.G. (2001) A polymorphic modifier gene alters the hypertrophic response in a murine model of familial hypertrophic cardiomyopathy. J. Mol. Cell. Cardiol., 33, 2055-2060.
45. Freeman, K., Lerman, I., Kranias, E.G., Bohlmeyer, T., Bristow, M.R., Lefkowitz, R.J., Iaccarino, G., Koch, W.J. and Leinwand, L.A. (2001) Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy. J. Clin. Invest., 107, 967-974.
46. Olsson, M.C., Palmer, B.M., Leinwand, L.A. and Moore, R.L. (2001) Gender and aging in a transgenic mouse model of hypertrophic cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol., 280, H1136-H1144.
47. Blanchard, E., Seidman, C., Seidman, J.G., LeWinter, M. and Maughan, D. (1999) Altered crossbridge kinetics in the αMHC403/+ mouse model of familial hypertrophic cardiomyopathy. Circ. Res., 84, 475-483.
48. 2+ activation of myofilaments from transgenic mouse hearts expressing R92Q mutant cardiac troponin T. Am. J. Physiol. Heart Circ. Physiol., 280, H705-H713.
49. Miller, T., Szczesna, D., Housmans, P.R., Zhao, J., de Freitas, F., Gomes, A.V., Culbreath, L., McCue, J., Wang, Y, Xu, Y. et al. (2001) Abnormal contractile function in transgenic mice expressing a familial hypertrophic cardiomyopathy-linked troponin T (I79N) mutation. J. Biol. Chem., 276, 3743-3755.
50. Tyska, M.J., Hayes, E., Giewat, M., Seidman, C.E., Seidman, J.G. and Warshaw, D.M. (2000) Single-molecule mechanics of R403Q cardiac myosin isolated from the mouse model of familial hypertrophic cardiomyopathy. Circ. Res., 86, 737-744.
51. Spindler, M., Saupe, K.W., Christe, M.E., Sweeney, H.L., Seidman, C.E., Seidman, J.G. and Ingwall, J.S. (1998) Diastolic dysfunction and altered energetics in the αMHC403/+ mouse model of familial hypertrophic cardiomyopathy. J. Clin. Invest., 101, 1775-1783.
52. Georgakopoulos, D., Christe, M.E., Giewat, M., Seidman, C.M., Seidman, J.G. and Kass, D.A. (1999) The pathogenesis of familial hypertrophic cardiomyopathy: early and evolving effects from an α-cardiac myosin heavy chain missense mutation. Nat. Med., 5, 327-330.
53. 26+ response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy. J. Clin. Invest., 106, 1351-1359.
54. Semsarian, C., Ahmad, I., Giewat, M., Georgakopoulos, D., Schmitt, J.P., McConnell, B.K., Reiken, S., Mende, U., Marks, A.R., Kass, D.A. et al. (2002) The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model. J. Clin. Invest., 109, 1013-1020.
55. Taigen, T., De Windt, L.J., Lim, H.W. and Molkentin, J.D. (2000) Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy. Proc. Natl Acad. Sci. USA, 97, 1196-1201.
56. Patel, R., Nagueh, S.F., Tsybouleva, N., Abdellatif, M., Lutucuta, S., Kopelen, H.A., Quinones, M.A., Zoghbi, W.A., Entman, M.L., Roberts, R. and Marian, A.J. (2001) Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circulation, 104, 317-324.
57. Lim, D.S., Lutucuta, S., Bachireddy, P, Youker, K., Evans, A., Entman, M., Roberts, R. and Marian, A.J. (2001) Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy. Circulation, 103, 789-791.
58. Freeman, K., Colon-Rivera, C., Olsson, M.C., Moore, R.L., Weinberger, H.D., Grupp, I.L., Vikstrom, K.L., Iaccarino, G., Koch, W.J. and Leinwand, L.A. (2001) Progression from hypertrophic to dilated cardiomyopathy in mice that express a mutant myosin transgene. Am. J. Physiol. Heart Circ. Physiol., 280, H151-H159.
59. Ostman-Smith, I., Wettrell, G. and Riesenfeld, T. (1999) A cohort study of childhood hypertrophic cardiomyopathy: improved survival following high-dose β-adrenoceptor antagonist treatment. J. Am. Coll. Cardiol., 34, 1813-1822.
60. Marks, A.R. (2001) Ryanodine receptors/calcium release channels in heart failure and sudden cardiac death. J. Mol. Cell. Cardiol., 33, 615-624.